五洲医疗
(301234)
| 流通市值：16.01亿 | | | 总市值：27.10亿 |
| 流通股本：4017.06万 | | | 总股本：6800.00万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 100,616,784.24 | 458,282,116.04 | 345,417,868.3 | 216,919,129.78 |
| 营业收入 | 100,616,784.24 | 458,282,116.04 | 345,417,868.3 | 216,919,129.78 |
| 二、营业总成本 | 95,348,895.49 | 441,702,032.61 | 328,356,715.98 | 207,769,077.17 |
| 营业成本 | 83,067,452.9 | 391,482,291.47 | 296,285,364.01 | 185,841,776.26 |
| 税金及附加 | 973,472.64 | 3,915,165.85 | 2,978,084.9 | 1,893,382.56 |
| 销售费用 | 3,591,216.86 | 18,222,120.67 | 11,799,884.1 | 7,839,442.56 |
| 管理费用 | 3,681,789.6 | 19,517,733.19 | 13,638,282.76 | 9,616,595.37 |
| 研发费用 | 2,043,691.55 | 9,741,167.79 | 5,727,947.61 | 4,404,357.82 |
| 财务费用 | 1,991,271.94 | -1,176,446.36 | -2,072,847.4 | -1,826,477.4 |
| 其中:利息费用 | 1,528.14 | 18,833.43 | 14,625.89 | 9,737.32 |
| 其中:利息收入 | 293,931.91 | 2,437,352.39 | -1,419,629.92 | 1,178,844.66 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 62,384.32 | -239,735.29 | 2,949.06 | -513,883.34 |
| 加:投资收益 | 1,230,871.23 | 5,521,436.77 | 3,671,037.32 | 2,701,838.79 |
| 资产处置收益 | 414,119.47 | -27,064.71 | 0 | 0 |
| 资产减值损失(新) | -1,538,191.07 | -2,708,572.21 | -1,394,652.68 | -1,285,805.69 |
| 信用减值损失(新) | 238,329.86 | 1,161,536.11 | 1,307,730.83 | 1,716,995.83 |
| 其他收益 | 3,575,141.67 | 3,233,535.19 | 2,831,242.31 | 1,900,052.16 |
| 四、营业利润 | 9,250,544.23 | 23,521,219.29 | 23,479,459.16 | 13,669,250.36 |
| 加:营业外收入 | 13,052.53 | 74,239 | 71,926.22 | 53,613.53 |
| 减:营业外支出 | 78,518.43 | 702,241.48 | 501,813.88 | 457,003.13 |
| 五、利润总额 | 9,185,078.33 | 22,893,216.81 | 23,049,571.5 | 13,265,860.76 |
| 减:所得税费用 | 1,134,096.88 | 4,000,195.23 | 4,540,182.34 | 2,750,730.9 |
| 六、净利润 | 8,050,981.45 | 18,893,021.58 | 18,509,389.16 | 10,515,129.86 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 8,050,981.45 | 18,893,021.58 | 18,509,389.16 | 10,515,129.86 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 8,050,981.45 | 18,893,021.58 | 18,509,389.16 | 10,515,129.86 |
| 扣除非经常损益后的净利润 | 5,157,453.69 | 14,410,635.17 | 14,816,474.26 | 8,339,152.15 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.12 | 0.28 | 0.27 | 0.15 |
| (二)稀释每股收益 | 0.12 | 0.28 | 0.27 | 0.15 |
| 九、综合收益总额 | 8,050,981.45 | 18,893,021.58 | 18,509,389.16 | 10,515,129.86 |
| 归属于母公司股东的综合收益总额 | 8,050,981.45 | 18,893,021.58 | 18,509,389.16 | 10,515,129.86 |
| 公告日期 | 2026-04-23 | 2026-04-23 | 2025-10-24 | 2025-08-21 |
| 审计意见(境内) | | 标准无保留意见 | | |